Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000354204-26-000274·CASTLE BIOSCIENCES INC
Schedule 13G ownership disclosure
Castle Biosciences Inc
Common Stock · CUSIP: 14843C105
Event date: 2025-12-31
- Filing-level shares
- 1,143,799.00
- Percent of class
- 3.9%
- Dimensional Fund Advisors LP
Shares: 1,143,799.00 · Class: 3.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000354204-26-000274
- Form type
- SCHEDULE 13G/A
- Filer
- CASTLE BIOSCIENCES INC
- CIK
- CIK 1447362
- Filed
- Jan 21, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership